The ABCD-Trial protocol outlines a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of B-cell depletion using rituximab in patients with amyotrophic lateral sclerosis. This study aims to provide insights into potential new treatment avenues for this challenging condition.
abcd trial study protocol for a randomized double blind placebo controlled study in patients with amyotrophic lateral sclerosis for the evaluation of efficacy and safety of b cell depletion with rituximab abcd
Original title: “ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD).”